Table 2 Procedural characteristics according to high thrombotic risk features
|  | HTR features (n = 4430) | Non-HTR features (n = 5018) | P value |
|---|---|---|---|
Left main or 3-vessel disease | 2682 (60.5) | 1841 (32.1) | < 0.001 |
Target vessel | |||
 Left main artery | 217 (4.9) | 51 (0.9) | < 0.001 |
 Left anterior descending artery | 3760 (84.9) | 5415 (94.4) | < 0.001 |
 Left circumflex artery | 1343 (30.3) | 465 (8.1) | < 0.001 |
 Right coronary artery | 1481 (33.4) | 394 (6.9) | < 0.001 |
 Bypass graft | 11 (0.2) | 6 (0.1) | 0.079 |
Number of lesion treated |  |  | < 0.001 |
 1 | 1976 (44.6) | 4802 (83.7) |  |
 2 | 1721 (38.8) | 935 (16.3) |  |
  ≥ 3 | 733 (38.8) | 0 (0.0) |  |
Number of stents implanted | 2.27 ± 1.00 | 1.34 ± 0.48 | < 0.001 |
Total lesion length, mm | 57.16 ± 30.18 | 24.98 ± 12.38 | < 0.001 |
Total stent length, mm | 60.76 ± 28.78 | 28.42 ± 12.20 | < 0.001 |
  Total stent length > 60 mm | 2052 (46.3) | 0 (0.0) | < 0.001 |
Mean stent diameter, mm | 2.91 ± 30.53 | 3.09 ± 0.57 | < 0.001 |
Diffuse multivessel disease in diabetic patients | 1882 (42.5) | 0 (0.0) | < 0.001 |
Bifurcation with two stents implanted | 428 (9.7) | 0 (0.0) | < 0.001 |
Treatment of chronic total occlusion | 836 (18.9) | 0 (0.0) | < 0.001 |
In-stent restenosis lesion | 201 (4.5) | 246 (4.3) | 0.543 |
Heavy calcified lesion | 229 (5.2) | 112 (2.0) | < 0.001 |
Thrombotic lesion | 194 (4.4) | 201 (3.5) | 0.023 |
Type B2 or C lesion | 3987 (90.0) | 3825 (66.7) | < 0.001 |
SYNTAX score | 14.75 ± 8.40 | 9.23 ± 6.79 | < 0.001 |
Glycoprotein IIb/IIIa use | 885 (20.0) | 764 (13.3) | < 0.001 |
Type of DES implanted | Â | Â | 0.703 |
 Early-generation DES | 453 (10.2) | 600 (10.5) |  |
 New-generation DES | 3977 (89.8) | 5137 (89.5) |  |
Radial approach | 3996 (90.2) | 5275 (91.9) | 0.002 |
Use of intravascular ultrasound | 338 (7.6) | 212 (3.7) | < 0.001 |